White Knight Strategic Wealth Advisors LLC Grows Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

White Knight Strategic Wealth Advisors LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 118.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,856 shares of the healthcare conglomerate’s stock after buying an additional 1,549 shares during the quarter. White Knight Strategic Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $1,445,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new stake in UnitedHealth Group during the fourth quarter worth $26,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $28,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth about $30,000. Finally, Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group during the fourth quarter worth about $30,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

NYSE UNH opened at $315.80 on Tuesday. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market capitalization of $286.47 billion, a PE ratio of 20.37, a P/E/G ratio of 1.37 and a beta of 0.56. The company has a fifty day moving average of $467.51 and a two-hundred day moving average of $511.49.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. During the same quarter last year, the business posted $6.91 earnings per share. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 2.66%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 35.18%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction on Wednesday, May 14th. The shares were bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the acquisition, the director now owns 6,033 shares of the company’s stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Kristen Gil bought 3,700 shares of the business’s stock in a transaction dated Thursday, May 15th. The shares were acquired at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the purchase, the director now owns 3,818 shares in the company, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders purchased 109,408 shares of company stock worth $31,607,768 over the last 90 days. 0.33% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Oppenheimer lowered their price objective on shares of UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a research report on Wednesday, May 14th. Argus cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, April 21st. Royal Bank of Canada lowered their target price on UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating for the company in a report on Friday. KeyCorp reduced their price target on shares of UnitedHealth Group from $575.00 to $450.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 14th. Finally, Erste Group Bank downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 30th. Eight research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $454.23.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.